D.E. Shaw & Co’s Celularity CELU Stock Holding History

D.E. Shaw & Co’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,138	Closed	-$6.06K	–	4279
2023 Q2	$6.06K	Buy	+1,138	New	+$7.29K	﹤0.01%	4096
2023 Q1	–	Sell	-7,604	Closed	-$98.1K	–	4482
2022 Q4	$98.1K	Buy	+7,604	New	+$140K	﹤0.01%	4367

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co's CELU Position: Q3 2023 in Review

D.E. Shaw & Co sold out of Celularity (CELU) in Q3 2023, closing a stake of 1,138 shares — an estimated $6.06K sold.

D.E. Shaw & Co first reported a position in CELU in Q4 2022 and held it in 2 quarters. The position peaked at $98.1K in Q4 2022. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

D.E. Shaw & Co reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
D.E. Shaw & Co sold 1,138 Celularity shares in Q3 2023, an estimated $6.06K.
D.E. Shaw & Co first reported a position in Celularity in Q4 2022 and held it in 2 quarters.
D.E. Shaw & Co's Celularity position peaked at $98.1K in Q4 2022.
45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.